
ZIVO Bioscience Issues Special Letter to Shareholders
ZIVO Bioscience shifts strategy to preserve capital and unlock shareholder value amid approaching revenue inflection point ZIVO Bioscience, Inc. has issued a detailed and strategically significant letter to shareholders from its Chairman, President, and Chief Executive Officer, John B. Payne,…













